Helen L. Ford

MS care: integrating advanced therapies and holistic management

L. Fisniku, Agne Straukiene, K. Schmierer, 2024, Frontiers in neurology.

Efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis (MS-SMART): a phase 2b, multiarm, double-blind, randomised placebo-controlled trial

S. Ourselin, F. Barkhof, D. MacManus, 2020, The Lancet Neurology.

The impact of reproductive issues on preferences of women with relapsing MS for DMTs

K. Schmierer, J. Chataway, Yasmina Okan, 2021 .

Patient perspective on decisions to switch disease-modifying treatments in relapsing-remitting multiple sclerosis.

K. Schmierer, J. Chataway, H. Bekker, 2020, Multiple sclerosis and related disorders.

Brain reserve and physical disability in secondary progressive multiple sclerosis

M. Duddy, A. Eshaghi, F. De Angelis, 2024, BMJ neurology open.